Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-02T13:22:41.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A notice appears at the top of the page about NIH website updates and the transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content.
    Difference
    0.8%
    Check dated 2026-10-26T15:33:36.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T16:28:25.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T16:32:44.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The Study Record History now shows a new revision entry, Revision: v3.7.0, while the previous Revision: v3.6.6 is removed from the history. This indicates a system release update to the record page rather than a change to the study data or core content.
    Difference
    0.1%
    Check dated 2026-09-21T20:59:49.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Version v3.6.6 was added to the study record history, and the previous v3.6.5 entry was removed from the log. This updates the version history to reflect the latest revision of the study record.
    Difference
    0.1%
    Check dated 2026-08-31T17:18:58.000Z thumbnail image

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.